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ABSTRACT The mitogen-activated protein kinase cascade is a conserved signal transduction pathway found in organisms of
complexity spanning from yeast to humans. In many mammalian tissue types, this pathway can correctly transduce signals from
different extracellular messengers, leading to speciﬁc and often mutually exclusive cellular responses. The transduced signal is
tuned by a complicated set of positive and negative feedback control mechanisms and fed into a downstream gene expression
network. This network, based on the immediate early gene system, has two possible, mutually exclusive outcomes. Using amath-
ematical model, we study how different stimuli lead to different temporal signal structure. Further, we investigate how each of the
feedback controls contributes to the overall speciﬁcity of the gene expression output, and hypothesize that the complicated
nature of the mammalian mitogen-activated protein kinase pathway results in a system able to robustly identify and transduce
the proper signal without investing in two completely separate signal cascades. Finally, we quantify the role of the RKIP protein
in shaping the signal, and propose a novel mechanism of its involvement in cancer metastasis.
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One of the most fascinating questions in cellular biology is
how a signal transduction network with one or more shared
components can accurately transmit multiple independent
signals from the cell surface to their proper targets (nucleus,
vacuoles, cytoskeletal junctions, etc.). Often, the subcellular
localization of the signal target is the same, but the distinct
signals elicit very different outcomes. The best studied of
this phenomenon is the PC-12 model system (1–3). PC-12
cells are rat-derived neural progenitor cells that can be
induced to proliferate upon epidermal growth factor (EGF)
stimulation, or to differentiate upon neural growth factor
(NGF) stimulation (3). In both cases, the signal is transduced
through the mitogen-activated protein kinase cascade
(MAPK) of Raf, Mek, and Erk (4,5). While some of the
biological details about how this pathway works and how
it evolved are still unclear, a general scheme for pathway
specificity has been uncovered. When stimulated with
EGF, PC-12 cells exhibit a transient spike in Raf, Mek,
and Erk activity, which quickly dies out back to background
levels. Induction with NGF causes a transient spike similar in
magnitude and duration, but in contrast to EGF stimulation,
the spike decays only partway, leading to a long-term, stable
level of Erk activity many hours after the initial stimulus
pulse (3,5). In the presence of an NGF signal, there is a posi-
tive feedback force acting from Erk to Raf, stabilizing Raf in
its active confirmation (2,3,6). This feedback mechanism is
suppressed under EGF signaling. The key mediator of this
suppression was identified as RKIP, a known inhibitor of
Raf kinase activity (3,6,7). This protein appears to not only
competitively block Raf’s ability to activate Mek, but also
through steric or other forces block Erk’s ability to phosphor-
ylate Raf. The working hypothesis is that a secondary
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0006-3495/09/05/3471/12 $2.00signaling pathway is activated upon NGF stimulation,
leading to a deactivation of RKIP and hence, enhancement
of the positive feedback loop. Several hypotheses concerning
the next step of the process, how the immediate early genes
(IEG) respond to transient and sustained Erk activity, have
also been proposed (8); however, the details of gene expres-
sion in response to the IEG activity are not known.
We hypothesize that signal transduction networks are opti-
mized to maintain the specificity of a given signal input in
a robust manner. An abstract definition of specificity is given
in Komarova et al. (9) to be the ratio of the correct output to
the spurious output of a signaling network relative to a given
input stimulus. This definition was then applied to several
simple network architectures involving multiple inputs and
outputs but at least one shared component can be tuned to
generate specificity under general conditions on the network
connection strengths and the character of the input stimuli.
Later work applied these abstractions to networks involving
scaffolding and cross-network inhibition (10). These defini-
tions have also been used to analyze the yeast pheromone
and stress response pathways (11). In this work, we extend
this concept of specificity to include robustness, which we
define as a network’s ability to properly interpret a wide
range of signal input profiles into the proper temporal output.
There is growing interest in investigating more complex
mammalian signal transduction pathways using theoretical
and computational approaches. The classic Raf-Mek-Erk
MAPK cascade has drawn much interest, especially concern-
ing receptor activation (12,13), internalization (14), and
cross-interactivity with other networks (15,16). These
computationally intensive models have been shown to be
robust in their parameterization (17,18). RKIP has been incor-
porated into several basic MAPK models with the goal of
better quantifying difficult-to-measure in vivo interaction
parameters (13,19). The MAPK/RKIP system has also been
modeled from a stochastic process algebra perspective;
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greatly explored (20). Work of a more theoretical nature has
focused on ideas of specificity within pathways with shared
components. The work of Behar et al. (21) demonstrated the
concept of kinetic insulation, based on adaptive feedback
mechanisms (22), in which two sets of enzymatic reactions
upstream of a single shared component interpret a signal for
transduction by transforming that signal into a specific
temporal and kinetic profile. Ueda and Shibata investigated
a simple stochastic model of the chemotactic sensing mecha-
nism of Dictyostelium to quantify the roles of different sour-
ces of noise in signaling processes, and to uncover regimes
of optimal signal/noise transduction (23).
In this work, we formulate and investigate a mathematical
model of both the major proteins involved in the MAPK
cascade (Raf, Mek, Erk, and RKIP) and the downstream
gene expression network that the cascade activates. We
explore how the output of the MAPK cascade ensures spec-
ificity of the IEG network in a robust manner. This expres-
sion network is represented by the canonical IEG protein
Fos and the two potential cell fate programs it can activate,
proliferation and differentiation. We hypothesize a simple
network architecture in which the differentiation program
can inhibit the proliferation program and show that under
proper stimulation input, based on biological observations,
this network is specific for both outputs.
We further explore how RKIP controls the long-term
dynamics of MAPK activity and demonstrate how each of
the control mechanisms contributes toward the specificity
of the network. These numerical experiments generate
predictions that can be translated into experimental studies.
Our results indicate that this network is designed to prevent
fluctuations in the temporal nature of the input signal from
spuriously activating the improper pathway without the
need to invest in two separate pathways. We also discuss
this hypothesis in the context of dysfunction of the control
mechanisms brought on by mutation and its consequences
for aberrant signal pathway behavior.
MODEL FORMULATION
MAPK cascade
The classic mammalian MAPK cascade involves a signal
transduced from a cell membrane receptor, such as a receptor
tyrosine kinase, to a membrane-associated intermediate, and
on to a series of protein kinases (24,25). These kinases act in
a sequential manner, each one activated by the kinase
directly upstream of itself and in turn activating the next.
The canonical pathway involves three kinases, Raf, Mek,
and Erk (see Fig. 1). We base this model on the work
summarized in Santos et al. (3). Raf is activated by the small
GTPase Ras upon proper upstream stimulation. Raf phos-
phorylates Mek, which then phosphorylates Erk, which
upon translocation into the nucleus activates a number ofBiophysical Journal 96(9) 3471–3482transcription factors important in IEG expression. Each
enzyme is inactivated by ubiquitous phosphatases found
throughout the cytoplasm. While the general orientation
and flow of signal information through this pathway has
been well established, recent work has also illustrated several
important feedback control mechanisms in this pathway.
Firstly, active Erk has an inhibitory effect on the signaling
scaffold built around the original receptor tyrosine kinase,
and thus will attenuate signal flowing from the extracellular
space even if the extracellular messenger remains for a pro-
tracted period. Secondly, under certain stimuli, Erk shows
a stabilizing effect on Raf activity. This stabilizing effect
is neutralized by the presence of a known inhibitor of
Raf, RKIP; the hypothesis therefore is that particular sig-
naling events lead to a decrease in RKIP levels or activity,
thus enhancing the feedback stabilization of Raf activity
by Erk.
To model this pathway, we make the following assump-
tions. Firstly, we assume Michaelis-Menten enzyme kinetics
govern flow of signal information down the pathway, as well
as any inhibitory mechanisms which block the flow of signal.
We also assume there are finite concentrations of total Raf,
Mek, and Erk available for activation, and so the pathway
is limited in its ability to continuously amplify a signal.
We also assume there is a finite amount of upstream trans-
duction machinery with a single limiting member. We list
each of the state variables for this system in Table 1.
Extracellular signal is input into the system in the form of
time-dependent functions SE(t) and SN(t). These functions
represent the extracellular concentrations of EGF (SE(t))
and NGF (SN(t)) in the PC12 system (3). The only functional
difference between them is that the SN(t) signal involves the
secondary signaling mechanism, which inactivates the RKIP
inhibitor (see Fig. 1). Both signal inputs activate upstream
signaling machinery at the same rate, dependent upon the
amount of inactive but competent transducer available (Eq. 1
below). Active transducer S(t) in turn activates Raf (R(t),
FIGURE 1 Schematic diagram of the MAPK cascade and IEG expression
network.
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via a first-order process. S(t) can also be inactivated by the
presence of active Erk (E(t)); however, this inactivation
event renders it into a form, SI(t), incompetent to become
active again for a period of time longer than the signal events
under consideration (Eq. 2). Active Raf converts inactive
Mek (M(t), Eq. 4) into its active form, and likewise Mek
converts inactive Erk to its active form (Eq. 5).
Finally, we assume the presence of an inhibitory molecule,
I(t), taken to be RKIP or an associated protein (Eq. 6). This
protein interferes with the pathway at two points. Firstly, it
blocks Raf from activating inactive Mek. Secondly, it
sequesters active Raf and thus prevents active Erk from
stabilizing it (6,7). These effects, while dependent upon the
same physical binding event, are separable from a modeling
perspective. Based on recent studies (3), this protein can be
inactivated by stimulation by NGF, one of the two principal
input mechanisms in the system (represented here by SN(t)).
As in receptor resensitization after inactivation, we do not
consider new inhibitor synthesis, as this will occur on a time-
scale longer than those under study.
The full system of equations governing the dynamics of
the MAPK cascade is
dS
dt
¼ ðSEðtÞ þ SNðtÞÞð1  S SiÞ  dsð1 þ eEÞS; (1)
dSI
dt
¼ dseES; (2)
dR
dt
¼ ksSð1  RÞ  dRR þ kRE 1  Rð1 þ IÞKR þ 1  R; (3)
dM
dt
¼ kMR 1 Mð1 þ IÞKM þ 1 M  dMM; (4)
dE
dt
¼ kEM 1  E
KE þ 1  E dEE; (5)
dI
dt
¼ kISNðtÞI: (6)
The model is nondimensional, with each variable describing
the fraction of each enzyme in the signal cascade that is
active, and with time normalized to the rate of signal input
TABLE 1 State variables for the MAPK-IEG network model
Component Variable
Active receptor complex S(t)
Disabled receptor complex SI(t)
Active Raf fraction R(t)
Active Mek fraction M(t)
Active Erk fraction E(t)
RKIP protein level I(t)
c-Fos protein level F(t)
Proliferation program level P(t)
Differentiation program level D(t)into the system. Following with the Michaelis-Menten
kinetics assumption, the action of the inhibitor will modify
the Michaelis-Menten rate equation dP=dT ¼ S=ðKappM þ SÞ
with the form KappM ¼ ð1 þ I=KIÞKM. We nondimensionalize
the inhibitor concentration by its binding affinity, which
leads to the functional terms (1 þ I)KR and (1 þ I)KM
seen in Eqs. 3 and 4, respectively. Parameters and their
values are listed in Table 2.
IEG expression network
The second module consists of the gene expression cassettes
induced by the transient and long-term activity of the MAPK
cascade (see Fig. 1, lower portion). The principle gene
product under consideration is c-Fos (F(t), Eq. 7), a member
of the IEG family of transcription factors. These genes are
quickly induced by Erk activity. Once translated, the proteins
typically have a very short half-life, and their levels quickly
fall back to background. However, in the presence of sus-
tained Erk activity, IEG gene products become stable,
leading to long-term transcription activation activity and
a secondary set of gene products being induced. This
secondary set of genes activates a separate cell fate program,
suppressing the activity of the first program. We take as our
model system the PC-12 neuronal differentiation model, and
therefore the competing outcomes are proliferation (P(t), Eq.
8) and differentiation (D(t), Eq. 9). We assume F(t) is
induced linearly by active E(t) and decays via a first-order
process; likewise, the cell fate products are induced linearly
via F(t) and decay with first-order kinetics. In addition, we
assume that the activity of the differentiation program,
D(t), is able to suppress the activity of the proliferation
TABLE 2 Parameters for the MAPK network model
Parameter Role Value Reference
ds Upstream signal inactivation rate 2 Estimate
3 Erk-mediated upstream
attenuation factor
1 Estimate
ks Receptor-mediated
Raf activation rate
1 (14)
kR Erk-mediated Raf activation rate 1.5 (14)
kM Raf-mediated Mek activation rate 2.9 (14)
kE Mek-mediated Erk activation rate 5.7 (14)
KR Michaelis-Menten constant
for Erk-Raf interaction
1.5 (14,28)
KM Michaelis-Menten constant
for Raf-Mek interaction
0.01 (14)
KE Michaelis-Menten constant
for Mek-Erk interaction
0.05 (14)
dR Raf inactivation rate 1 Estimated from
]Schoeberl et al. (14)
dM Mek inactivation rate 2 Estimated from
Schoeberl et al. (14)
dE Erk inactivation rate 2 Estimated from
Schoeberl et al. (14)
References are provided for parameters when available; otherwise parame-
ters are marked as estimates. Representative values used in simulations
are provided as well.Biophysical Journal 96(9) 3471–3482
3474 Thalhauser and Komarovaprogram. This assumption is based on the mechanisms of
cell-cycle arrest in differentiation found in the literature
(26,27) while maintaining the idea that P and D are the
net activities of the respective programs, and not any one
representative effector. If we assume E(t) follows the
dynamics described above, then the model for the second
module is
dF
dt
¼ kFE dFF; (7)
dP
dt
¼ kPF dPð1 þ dDÞP; (8)
dD
dt
¼ kDF dDD: (9)
Parameters for this module are listed in Table 3.
Speciﬁcity
We define specificity as in the literature (9,10), in which the
specificity of a pathway relative to a given input is the total
amount of proper pathway output divided by the spurious
pathway output. We introduce the notation that PE(t) is the
amount of proliferation product at time t in response to the
SE(t) signal; likewise, PN(t) is the amount of proliferation
product in response to the SN(t) signal. Then the specificity
of the pathway in response to an EGF stimulus is
TABLE 3 Estimated parameters for the IEG network model
Parameter Role Estimated value
kF Erk-mediated Fos production rate 1
dF Fos inactivation rate 1.5
kP Fos-mediated proliferation induction rate 10
dP Proliferation program inactivation rate 1
kD Fos-mediated differentiation induction rate 0.04
dD Differentiation program inactivation rate 0.01
d D-mediated P inhibition factor 10SP ¼
R
PEðtÞdtR
DEðtÞdt; (10)
while in the presence of NGF, the specificity is
SD ¼
R
DNðtÞdtR
PNðtÞdt : (11)
We will also use the idea of mutual specificity in analyzing
this pathway. Mutual specificity of degree k is defined as
the regime of possible architectures (inputs and connection
strengths) in which all possible outputs of a pathway with
shared components demonstrate specificity >k (9).
Simulations
All simulations were performed in MATLAB R14 (The
MathWorks, Natick, MA) using the ODE15s integrator.
Simulations were computed to Tf ¼ 100 min post signal
input time. For the given input signal,
SEðtÞ ¼ S0 0 < t < T00 T0%t < Tf ;

with some value of signal strength S0 and duration T0, then
the specificity SP is
SP ¼
R Tf
0
PðtÞdtR Tf
0
DðtÞdt
;
and likewise for a SN(t) input. Specificities (Figs. 2, 4, and 8–
10) were computed numerically by integrating the complete
time series solutions according to the definitions in Bardwell
et al. (10) using the MATLAB quadl function. For Fig. 5, T1
is measured as the width of the primary peak at half-height
above the long-term steady-state value of F. In Fig. 6, F1
is computed as the average value of the F signal up to the
computed T1 point. And, in Fig. 7, F2 is the steady-state
height of the F signal past the peak (be it zero or nonzero).FIGURE 2 Representative simulations of the MAPK
model (top row) and IEG network (bottom row) with
SE(t) (left) or SN(t) (right) stimulation input. Computed
specificity (Eqs. 10 and 11) of each IEG network output
is included. Both input pulses are of magnitude 1 and dura-
tion 15 min.
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and T1.
The MAPK cascade
The temporal signal structure
Representative simulations of the complete model, Eqs. 1–9,
are shown in Fig. 2 for SE(t) and SN(t) input, along with plots
of the resulting P(t) and D(t) production and the computed
specificity for each case. All simulations were performed
using the ODE15s solver routine from MATLAB.
As is observed experimentally, upon SE(t) stimulation
there is a transient rise in MAPK activity levels, which
then decay back to background levels. This transient spike
induces sharp production of the P(t) genetic program and
only lesser amounts of the D(t) program, leading to speci-
ficity favoring the former. In the case of SN(t) induction,
the transient spike is still observed; however, it decays
only partially and settles instead into a long-term sustained
activity level. This long-term activity is successful in switch-
ing the specificity of the downstream expression network to
favor the D(t) product.
The twofold role of RKIP in shaping the output signal
We first study numerically how changes in the inhibitor level
affects the long-term dynamics of the Erk signal. We adjust
the model slightly by treating the inhibitor as a constant and
perform a bifurcation analysis (i.e., we remove Eq. 6 from
the system and instead treat I(t)h i). The results of this anal-
ysis are shown in Fig. 3. Since there are, in principle, two
mechanisms of control, even though they are linked by
a single binding event, we investigate the effects each one
has independent of the other on the system, and then we
combine them. As seen in Fig. 3, the RKIP effect of seques-
tration of Raf is far more important from the standpoint of
long-term Erk signal suppression than interruption of the
signal flow from Raf to Mek. Moreover, combining the
two mechanisms leads to only a very modest improvement
in signal suppression. Thus, we hypothesize that the two-
phase nature of the system evolved around the steric inhibi-
tory effects the large molecule inhibitor RKIP has on Raf
FIGURE 3 Steady-state magnitude of E(t) as a function of inhibitor (i)
level. Plots represent a purely forward inhibitory role, a purely feedback
sequestration role, or both mechanisms (as marked).kinase, and that direct Raf-to-Mek signal interruption by
RKIP is important in other contexts.
We can gain insight into the cause of the disparity between
these two control mechanisms by studying the steady-state
equations for the MAPK pathway. Since there are no control
mechanisms acting directly upon Erk, we make the same
approximation as before (the linear approximation to Mi-
chaelis-Menten kinetics and the quasi-steady state assump-
tion), and thus, have nonlinear steady-state equations for
Raf and Mek only,
0 ¼ dRR þ kREðMÞ 1  Rð1 þ iÞKR þ 1  R
0 ¼ kMR 1 Mð1 þ iÞKM þ 1 M  dMM:
These equations seem, at first glance, nearly symmetric, and
thus, one might expect each of the two control points to exert
equal influence on the pathway outcome. However, the
symmetry is broken by the nondimensional parameters KR
and KM. While each enzyme in question, Erk and Raf,
have similar affinities for their targets, the large disparity
in expression number between the substrates implies
KR >>KM. In particular, it has been observed that the kinetic
parameter values for Raf, Mek, and Erk are nearly the same
(28). On the other hand, the abundance of the Raf protein is
much lower relative to that of Mek and Erk (14). Therefore,
the value for the scaled parameter KR is much higher relative
to the others. Thus, a similar amount of inhibitor will be able to
change the dynamics of the Raf stabilization reaction to
a much greater extent than the Mek activation reaction. This
leads us to the hypothesis that RKIP’s role in the modulation
of Erk’s long-term dynamics evolved separately from its role
as a direct inhibitor of Raf activity.
IEG network driven by the MAPK pathway
Speciﬁcity in the IEG network
We begin by analyzing the potential specificity mechanisms
of the gene expression network relative to the temporal
activation profiles observed in the in vitro experiments. A
network with a similar basic architecture was analyzed previ-
ously (10). It was found that mutual specificity could be
attained when the stimuli were simple square pulses whose
durations were longer than the timescale of inactivation for
each network member. This assumption allowed the authors
to make a quasi-steady-state approximation on the levels of
active network elements and derive specificity criteria based
on the model parameters. We now extend this analysis to
consider a biphasic input pulse similar to that produced by
the upstream MAPK cascade.
The gene network receives two distinct input signals: a
transient spike that decays quickly to zero, induced by
EGF; and a similar transient spike that decays quickly to a
nonzero, long-term active state, induced by NGF. These sig-
nal inputs can be represented qualitatively by a combinationBiophysical Journal 96(9) 3471–3482
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mined specificity and the strict analytic bound for various
initial pulse durations and pulse amplitude ratios. (Left)
An idealized schematic representation of the two observed
temporal profiles of c-Fos. The upper plot shows c-Fos
dynamics under a typical EGF input signal, in which the
protein is quickly induced and then quickly falls back to
baseline; whereas the lower plot shows c-Fos dynamics
after a typical NGF signal, in which the protein is quickly
induced and then falls to a long-term intermediate level
before returning to baseline. (Right) Contours of network
specificity levels subject to the constraint that mutual spec-
ificity is >1 are plotted, along with the region determined
by conditions 12 and 13. Parameters as listed in Table 3.of square-wave pulses. Both situations involve a pulse of
amplitude F1 and duration T1. In the EGF case, this is the
only signal input into the expression network. However, in
the NGF case, there is an additional square-wave pulse of
amplitude F2, which terminates at time T2. We make the
restrictions that F1 > F2 and T2 – T1 > T1; that is, the first
signal pulse is strong, but of much shorter duration, than the
second (see Fig. 4, left panel).
It is not possible to compute the integrals in the definition
of specificity analytically for the equations given for the IEG
network. However, we can compute bounds that can be
useful for defining regimes in which specificity for both path-
ways is possible. We first consider the specificity of the EGF
signal (Eq. 10). For a given square-wave input pulse, we can
directly compute from Eq. 9 that DðtÞ ¼ F1kD=dDð1
edDtÞ. Since F1 > 0 only when t < T1, the maximum value
for D(t) is D1 ¼ DðT1Þ ¼ F1kD=dDð1  edDT1Þ. Substitu-
ting this value into Eq. 8 in place of the D(t) nonlinearity
yields a linear equation. We can then compute the total
amounts of each network output and determine the speci-
ficity to be
SP ¼ kPdD
dPkDð1 þ dD1Þ:
Rearranging this condition under the goal of specificity >1
yields
kP
dP
 kD
dD
>
kD
dD
dD1 ¼ d

kD
dD
2
F1

1  edDT1: (12)
We perform a similar analysis in the context of the two-step
signal, to yield the following condition for specificity
(Eq. 11):This condition is cumbersome, but under the assumptions
that T2 >> T1 and F1 ¼ 1 (that is, we normalize the first
signal pulse), it reduces to
SD ¼
kDdP

1 þ dkD
dD
F2

dDkP
;
which we can rearrange to yield a condition to provide spec-
ificity >1:
kP
dP
 kD
dD
< dF2

kD
dD
2
: (13)
We can combine Eqs. 12 and 13 into a single compatibility
condition for mutual specificity for both pathways under
both input regimes:
T1 <  1
dD
ln

1  F2
F1

¼ 1
dD
ln

F1
F1  F2

: (14)
Thus, we obtain an upper bound for the duration of the
initial, high intensity pulse as a function of the lifetime of
the D class gene products and the ratio of the amplitudes
between the initial and long-term signal inputs. Also note
that if F2 ¼ 0, mutual specificity is impossible; this is very
reasonable, as the D program is designed to gain specificity
only in the presence of the second pulse.
Since these bounds were derived by making stricter
assumptions than necessary, we compare the analytic
condition required for mutual specificity to a numerical
experiment in which the first pulse time, T1, and ratio of
second to first pulse amplitude, F2=F1, are varied for fixed
values of d, dD, and kP=dP  kD=dD. These results are
summarized in Fig. 4. In this figure, we present a contour
plot of the network specificity, S ¼ SPSN, in regimes ofSD ¼

ðF1  F2ÞkD
dD
T1 þ F2kD
dD
T2

1 þ ðF1 þ F2ÞdkD
dD
þ

d
kD
dD
2
F1F2

kP
dP
ðF1  F2ÞT1 þ F2T2

1 þ dkD
dD

kP
dD
:
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mutual specificity, we set network specificity to 0 for
contrast. We also plot the theoretical bounds for T1 and
F2 determined under the strict assumptions discussed in
the preceding section.
As seen in Fig. 4, the system exhibits mutual specificity in
a regime bounded above by T1 ~10 for a wide range of
F2=F1. The analytic bound on F2 is very accurate, whereas
the bound for T1 is much stronger than necessary, which is
to be expected given the assumptions made to compute it.
However, the results clearly indicate the need to bound the
duration of the high intensity pulse so that specificity may
be achieved. We also observe how T1 and F2 relate in
providing for mutual specificity for P(t) and D(t) output.
We see that, up to a threshold for T1, mutual specificity for
a system with fixed T1 can be increased by increasing F2
(which provides more input strength into the D program).
Conversely, for a system with fixed F2, mutual specificity
can be increased by decreasing T1 (which more clearly delin-
eates the separation between P and D).
Given these conditions, we can now return to the model of
the MAPK pathway, and investigate how the complex
connections affect the key parameters, which themselves
determine specificity. We consider the full model introduced
above, and perform numerical experiments to study why
such a complex interweaving of control systems may be
necessary by removing key feedback control loops and
assessing their impact.
The role of input signal strength and duration
in shaping c-Fos dynamics
Equation 14 shows how the magnitude and duration of the
two input pulses into the IEG expression network effect
the mutual specificity of the network output. We next explore
how factors that are controllable in the in vitro laboratory
experiments, namely the strength and duration of exposure
to the extracellular messengers, affect the signal inputs into
the gene expression system. We measure the magnitude of
the transient and long-term F(t) signals, and compute the
duration of the F1 phase as the width of the transient peakat half-height above the steady-state F(t) magnitude. (We
experimented with different methods to obtain F1 and T1
and found no qualitative differences in the results. F1 can
also be computed by taking it to be the maximum value of
the initial F signal peak, and then T1 by approximating the
area under the F peak as a rectangle with height F1 and width
T1. These results were virtually identical to those given in the
text.)
We first study the impact of extracellular signal strength
and duration on the duration of the initial c-Fos expression
pulse, T1. The results of this experiment are found in
Fig. 5. The simulation demonstrates that the system’s
intrinsic shutdown mechanism, presumed to be caused by
the negative feedback loop from Erk to the receptor complex,
is strongly dependent upon the magnitude of the incoming
signal, and that a threshold amount of stimulus must be
exerted to activate it. Further, there is little distinction
between the two input stimuli, implying the duration of the
initial IEG expression burst is independent of which receptor
has been activated.
The magnitude of the Fos transient under both SE(t) and
SN(t) stimulation is shown in Fig. 6. This response is surpris-
ingly insensitive to input duration, suggesting the upstream
machinery becomes quickly saturated upon stimulation.
The system also displays saturation kinetics as a function
of input magnitude. We note that the SN(t) signal allows
for a steeper climb to threshold as a function of input magni-
tude than the SE(t) input, and the steepness is itself time-
dependent. This is likely due to the slow degradation of
RKIP caused by the SN(t), but not SE(t), signal.
As shown in Fig. 7, no combinations of input signal dura-
tion or strength allow the SE(t) signal to generate a long-term
Fos signal, in accordance with experiments. Moreover, even
at high input strengths, there is a minimum signal time neces-
sary for the SN(t) input to generate a long-term Fos response.
This correlates very well with the observation that, in PC-12
cells, the NGF-specific signal profile can be disrupted by
interfering with its receptor, but only up to a critical time
point; after this time, the NGF signal pattern is established
and further loss of the receptor or extracellular signal does
not collapse the internal response.FIGURE 5 T1 duration as computed from the MAPK
model as a function of input signal strength for specified
signal durations (T0) (left column) or of input signal dura-
tion for specified signal strengths (S0) (right column) of
SE (top row) or SN (bottom row) input.
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3478 Thalhauser and KomarovaFIGURE 6 F1 magnitude as computed from the MAPK
model as a function of input signal strength for specified
signal durations (T0) (left column) or of input signal dura-
tion for specified signal strengths (S0) (right column) of
SE (top row) or SN (bottom row) input.Robustness of the MAPK-IEG network
We next explore the relative contributions to mutual speci-
ficity each feedback control mechanism provides to each
input signal. We investigate three possible modifications to
the MAPK model, by removing the positive feedback loop
from E to R (kR ¼ 0), removing the negative feedback
loop from E to S (3 ¼ 0), or both. We summarize the charac-
teristics of these four models in Table 4.
We numerically simulated each of these four possibilities
over a wide range of extracellular messenger stimulation
strengths and times, to assess regimes of input signal in
which each achieves both maximum individual specificity
as well as maximum mutual specificity for the network.
Since both stimuli activate the same pathway, we seek to
measure what role, if any, the dynamic nature of the stimulus
input has in determining the pathway output. Pathways in
which the temporal nature of the stimulus (i.e., signal
strength and magnitude) can itself strongly determine the
outcome without regard to the identity of the stimulus will
be very sensitive to fluctuations in the extracellular
messenger. Individual output specificities for each model
network are shown in Figs. 8 and 9 for the SE(t) and SN(t)
inputs, respectively.
Fig. 8 clearly demonstrates that the Erk-to-Raf positive
feedback plays no role in properly interpreting the SE(t)
signal (compare models 2 and 4). However, loss of the Erk
to S negative feedback (models 1 and 3) severely limits theability of the system to transduce a wide range of SE(t)
stimuli. Loss of this mechanism leads to a decrease in spec-
ificity during long duration stimulation for all but very weak
signal stimuli, which implies a spurious long-term Erk signal
is being generated and thus, forcing the IEG network toward
the differentiation output.
As seen in Fig. 9, all models also show a lower bound for
input duration necessary for proper signal integration, in
accordance with the biological literature. Loss of the Erk-
mediated receptor attenuation mechanism (models 1 and 3,
respectively) both enhances the specificity of the SN(t) input
and allows for a broader range of properly interpreted input
signals. However, comparisons between Figs. 8 and 9 for
models 1–3 show minimal regions of overlap between their
respective areas of high specificity for each signal input.
The results for model 1 also confirm the analysis per-
formed earlier on a network with the same architecture as
the IEG system here (10). In their steady-state analysis, the
authors found mutual specificity could be attained in this
system only if two different types of input stimuli were
considered: one long but weak, the other strong but short.
Since the MAPK network presented here without any feed-
back mechanisms (i.e., model 1) merely serves as an ampli-
fier that responds to each input source equally, we expect
specificity to depend entirely on the temporal nature of the
input signal, and for mutual specificity, to a single type of
input from both sources (same strength, same duration) to
be incapable of ever providing mutual specificity.FIGURE 7 F2 magnitude as computed from the MAPK
model as a function of input signal strength for specified
signal durations (T0) (left column) or of input signal dura-
tion for specified signal strengths (S0) (right column) of
SE (top row) or SN (bottom row) input.
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network specificity, shown in Fig. 10. Here too we plot the
specificity of the full MAPK-IEG network only in regions
of mutual specificity. The role of the feedback mechanisms
is striking. The systems with no positive feedback (models
1 and 2) show no mutual specificity at all, while model 3
shows an extremely small regime of mutual specificity.
Conversely, the full MAPK model gives mutual specificity
>1 over a vast range of possible input strengths and dura-
tions. It indicates a minimum signal strength and duration
necessary for both pathways to be specific, in accordance
with the F1 and T1 studies presented above. Thus, we
hypothesize that the feedback control mechanisms allow
the system to properly interpret the nature of the input signal
by greatly reducing the impact any fluctuations in signal
delivery may have on the downstream pathways, without
the need to maintain two completely separate pathways.
Mutual specificity implies that there is a regime of input
signal dynamics for which the proper signal is transmitted
without excess spurious output. Thus, the mechanisms
ensure that a long EGF signal that acts like an NGF signal
does not induce an NGF response; only the character of
the signal (EGF versus NGF) is important.
Fig. 10 shows the boundaries for mutual specificity for
signal inputs of identical dynamics (i.e., strength and dura-
tion) but different nature (i.e., EGF versus NGF). Our
hypothesis is in part that the various feedback mechanisms
could at least partially insulate the system from temporal
variations in the original input signal. Comparing the
lower-left and upper-right panels of Figs. 8 and 9 show
this is the case: in the presence of a fully functional feedback
system, the P program gains specificity even under pro-
tracted signal inputs at the cost of specificity for the D
TABLE 4 Listing of alternate models to the system of Eqs. 1–9
Model Characteristic Implementation
1 No feedback kR ¼ 0, Eq. 3; 3 ¼ 0, Eqs. 1 and 2
2 No positive feedback kR ¼ 0, Eq. 3
3 No negative feedback 3 ¼ 0, Eqs. 1 and 2
4 Original MAPK model Eqs. 1–9program only over a small regime of short signal input.
Taken together, these simulations show that the feedback
system provides a measure of insensitivity to dynamics of
the input signal.
While Fig. 10 demonstrates how loss of any of the control
mechanism completely ablates specificity in the system, it is
also important to note that the data in Fig. 4 coupled with
Figs. 5–7 clearly demonstrate that the system has higher
specificity. Fig. 5 shows the how the mutual specificity of
the IEG system depends on the temporal structure of its input
(via c-Fos), and yields a large regime of mutual specificity of
~6 or greater; while Figs. 5–7 demonstrate how input into the
MAPK system determine the structure of the c-Fos response.
In general, mutual specificity is increased with longer input
pulses, which allows the D(t) program to more clearly distin-
guish itself from the P(t) program.
DISCUSSION
The central questions in qualitatively analyzing the mamma-
lian MAPK cascade are how the cell maintains the integrity
of the pathway when it is used in transducing very different
signals, and how differences in activity states of the pathway
in response to different stimuli can lead to very different
genetic responses. In this work, we have shown how a single
pathway with one auxiliary protein, which is differentially
controlled based on signal inputs, can lead to two very
different cell fates by driving a relatively simple gene expres-
sion network. The signal network is designed to provide
robust interpretation of the extracellular signal into one of
two distinct temporal profiles independent of the temporal
profile of the input signal itself. The expression network is
tuned to these profiles so that upon the eventual termination
of the signal, the proper product is dominant.
Theoretical and empirical connections
The results presented here lend themselves quite naturally to
experimental exploration. Firstly, we have hypothesized that
the purpose of the joint network is to insulate the genetic
response from fluctuations in the input signals to the greatestFIGURE 8 Specificity of the model networks in
response to the SE(t) input signal. Parameters as in Tables
2 and 3, except as noted in Table 4.
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3480 Thalhauser and KomarovaFIGURE 9 Specificity of the model networks in
response to the SN(t) input signal. Parameters as in Tables
2 and 3, except as noted in Table 4.extent possible. The temporal profiles of the Fos signal are
quite stable over a wide range of extracellular stimuli
(Figs. 5–7). Each of the features of this profile, namely the
length and magnitude of the initial transient as well as the
magnitude of the long-term signal, can be measured
in vitro under varied stimulation scenarios. Also, specific
intervention in the feedback control loops, for example via
point mutation ablation of the Erk-mediated receptor
complex inactivation, can be used to confirm or refute the
hypotheses generated by the reduced models (e.g., Fig. 8),
and show how loss of these control mechanisms leads to
changes in the joint network specificities.
This analysis also lends insight into how changes in the
members of this pathway may lead to aberrant signal pro-
cessing. As seen in Fig. 3, a mutation leading to either
a loss of expression or a truncation of the inhibitor protein,
so that it is only competent to perform the direct Raf inhib-
itory effects (but not the sequestration effects), would render
the cell incapable of properly transducing a signal to generate
a transient Erk activity spike but no long-term activity. This
phenomenon also has implications in the development ofsmall molecule inhibitors of Raf activity (29). Fig. 3 demon-
strates that a small molecule inhibitor, which blocks only Raf
activity, will not fully rescue the loss of RKIP activity.
The metastatic site selection hypothesis
While in the model system of this work, the PC-12 system,
loss of RKIP activity leads to a loss of proliferative potential,
in other cell systems long-term Erk activity is a driving force
for proliferation, in which the transient spike leads to a non-
proliferative state (8). Thus, such an occurrence would have
the potential to drive cells into an unnatural proliferative state
by transforming a nonmitogenic signal into a mitogenic one.
It is well established that the MAPK pathway itself plays
a prominent role in many forms of cancer (29,30). Loss of
RKIP activity itself has been identified as a marker of malig-
nancy in hepatocellular carcinoma, via aberrant signal pro-
cessing through the IGF-1/MAPK system. Furthermore, it
has been observed that RKIP is a suppressor of metastasis
in several tumor types (31,32); however, the mechanism
underlying this observation is unknown. Conversely, recentFIGURE 10 Network specificity in regions of mutual
specificity for IEG output of MAPK pathways. Parameters
as in Tables 2 and 3, except as noted in Table 4.
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lation of migration in MDCK cells (33,34).
The results presented here offer a novel hypothesis for yet
another mechanism by which RKIP might affect metastasis.
The predicted misinterpretation of extracellular signals (Figs.
8 and 9 and (3)) to a loss of RKIP activity might indicate that
cells with ablated RKIP activity have more potential regions
in which they can successfully colonize and form secondary
tumors. Factors native to those regions, which might be
suppressive to cells with active RKIP, may now induce
permissive signals due to aberrant signal transduction. This
suggests that RKIP-deficient strains will undergo positive
selection in tissue regions rich with cytokines and other
factors which trigger an abnormal proliferative signal,
whereas strains with full, normal RKIP find those same
regions as unsupportive of colonization. We summarize
this metastatic site selection hypothesis in Fig. 11.
This hypothesis is testable. The factors native to the
known preferential metastatic targets of RKIP positive and
RKIP negative tumor strains can be examined. In the
RKIP negative strains, any receptor-cytokine pairing capable
of activating the MAPK pathway would lead to a sustained
ERK, pro-growth signal. However, in the RKIP positive
cells, only those receptors that also activate the secondary
pathway (such as the SN(t) signal in Fig. 1) would lead to
a sustained ERK signal, and thus we would expect to observe
enrichment of those receptors at the metastatic site.
Further on, it would be interesting to investigate the selec-
tive environment of the primary tumor sites. Are there selec-
tive pressures for or against the expression of RKIP? Or is it
a neutral trait in the primary tumor? In the latter case, the
following simple calculation is possible (see (35,36)). If
the mutation rate by which RKIP negative mutants are
created is given by u, and N is the size of the primary tumor,
FIGURE 11 Schematic representation of the metastasis site selection
hypothesis, in which strains bearing a loss of RKIP activity have preferential
site selection and competitive exclusion advantages over strains still contain-
ing RKIP.then (in the absence of deaths in the colony of cells), the frac-
tion of mutant cells in the tumor is given roughly by u log N.
It follows that if the mutation rate is ~107 RKIP mutations
per cell division, then the fraction of mutants in a tumor of
size N ¼ 108 is ~1.8  106. This means that only a negli-
gible fraction of cells contains mutations in the RKIP gene,
and given that the process of metastases is extremely ineffi-
cient (see (37)), such cells would hardly make a difference in
creating new colonies. Also, this estimate is at odds with
experimental data suggesting that the level of RKIP expres-
sion is low even at the primary tumor locations (38). There
are two ways to resolve this inconsistency:
1. RKIP mutants have a selective advantage at the primary
site.
2. The mutation rate is higher than the basic rate quoted
above, as a result of genetic instability.
There is evidence that both chromosomal instability (39)
and microsatellite instability (40) are observed in hepatocel-
lular carcinomas, and that they are correlated with metastases
(41). Thus, an experimental test of hypothesis 1, directly
above, would greatly aid in our understanding of the internal
dynamics of RKIP mutants at the primary site.
Presently we are developing a stochastic model of mutant
generation that will take in the information on the mutation
rate and selective pressures inside the tumor. The goal is to
create a theoretical method to evaluate the probability distri-
bution for the number of mutants in a colony of a given size,
in a system where the mutations confer a selective advan-
tage. We are also working on developing tools to answer
the following question: how early does the tumor adaptation
have to start to make metastases possible at later stages?
CONCLUSION
We have generated a mathematical model of the MAPK-IEG
network system in the context of the PC-12 proliferation/
differentiation model. While the feedback mechanisms
modeled in this article are well established in recent experi-
mental results (3), our goal in this work was to explore how
these regulatory mechanisms effect the specificity of the
pathway. Further, we investigated how the theoretical foun-
dations of specificity could be used to explain the effects of
malfunctions in these mechanisms, and understand how they
lead to the results that are observed in experiments. The
combined pathway, which contains both MAPK and IEG
networks, has never been considered. Since the entire core
pathway is shared in this system, and the only difference
lies in the auxiliary feedback mechanisms, this is a new class
of pathway in which the concepts of specificity have been
applied. Our analysis further demonstrates how specificity
can be useful in generating hypotheses concerning broader
consequences from the localized failures in a particular
segment of a network. In particular, we present a hypothesis
about the role of RKIP in metastatic site selection.Biophysical Journal 96(9) 3471–3482
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